Beacon Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Sell
112,362
-2,394
-2% -$315K 0.53% 49
2026
Q1
$16M Buy
114,756
+3,225
+3% +$452K 0.66% 46
2025
Q4
$13.7M Buy
111,531
+10,449
+10% +$1.27M 0.56% 49
2025
Q3
$11.2M Buy
101,082
+4,195
+4% +$477K 0.47% 56
2025
Q2
$10.7M Buy
96,887
+10,226
+12% +$1.09M 0.47% 59
2025
Q1
$9.71M Buy
86,661
+6,429
+8% +$663K 0.45% 63
2024
Q4
$7.41M Buy
80,232
+3,637
+5% +$327K 0.32% 73
2024
Q3
$6.42M Buy
76,595
+1,048
+1% +$80K 0.27% 79
2024
Q2
$5.18M Sell
75,547
-317
-0.4% -$21.2K 0.22% 83
2024
Q1
$5.56M Buy
75,864
+1,493
+2% +$115K 0.24% 81
2023
Q4
$6.02M Buy
74,371
+923
+1% +$71.8K 0.27% 82
2023
Q3
$5.5M Sell
73,448
-547
-0.7% -$42.1K 0.27% 79
2023
Q2
$5.7M Sell
73,995
-384
-0.5% -$30.6K 0.26% 82
2023
Q1
$6.17M Buy
74,379
+571
+0.8% +$47.3K 0.3% 76
2022
Q4
$6.34M Buy
73,808
+892
+1% +$70.6K 0.32% 69
2022
Q3
$4.5M Sell
72,916
-311
-0.4% -$19.6K 0.25% 81
2022
Q2
$4.53M Buy
73,227
+563
+0.8% +$34.9K 0.24% 89
2022
Q1
$4.32M Buy
72,664
+1,523
+2% +$97.4K 0.18% 96
2021
Q4
$5.17M Sell
71,141
-129
-0.2% -$8.88K 0.2% 93
2021
Q3
$4.98M Sell
71,270
-147
-0.2% -$10.3K 0.21% 90
2021
Q2
$4.92M Buy
71,417
+6,327
+10% +$422K 0.2% 94
2021
Q1
$4.21M Buy
65,090
+3,507
+6% +$226K 0.18% 97
2020
Q4
$3.59M Buy
61,583
+3,834
+7% +$231K 0.17% 98
2020
Q3
$3.65M Buy
57,749
+39,679
+220% +$2.75M 0.19% 91
2020
Q2
$1.39M Sell
18,070
-2
-0% -$153 0.08% 131
2020
Q1
$1.35M Buy
18,072
+85
+0.5% +$5.87K 0.1% 123
2019
Q4
$1.17M Sell
17,987
-710
-4% -$46.2K 0.06% 134
2019
Q3
$1.19M Sell
18,697
-180
-1% -$11.8K 0.12% 109
2019
Q2
$1.27M Sell
18,877
-15,302
-45% -$1.01M 0.14% 101
2019
Q1
$2.22M Sell
34,179
-27,482
-45% -$1.83M 0.24% 88
2018
Q4
$3.86M Sell
61,661
-4,856
-7% -$339K 0.43% 65
2018
Q3
$5.14M Sell
66,517
-1,085
-2% -$81.9K 0.5% 58
2018
Q2
$4.79M Sell
67,602
-7,671
-10% -$542K 0.48% 61
2018
Q1
$5.67M Buy
75,273
+11,179
+17% +$889K 0.59% 53
2017
Q4
$4.59M Buy
64,094
+434
+0.7% +$33K 0.49% 62
2017
Q3
$5.16M Buy
63,660
+46,504
+271% +$3.56M 0.44% 66
2017
Q2
$1.21M Buy
17,156
+344
+2% +$22.9K 0.22% 18
2017
Q1
$1.14M Buy
16,812
+262
+2% +$18.4K 0.22% 17
2016
Q4
$1.19M Buy
16,550
+51
+0.3% +$3.79K 0.23% 15
2016
Q3
$1.3M Sell
16,499
-1,636,646
-99% -$133M 0.29% 11
2016
Q2
$1.38M Buy
1,653,145
+1,636,698
+9,951% +$145M 0.3% 9
2016
Q1
$1.51M Sell
16,447
-355
-2% -$32K 0.32% 7
2015
Q4
$1.7M Hold
16,802
0.32% 10
2015
Q3
$1.65M Hold
16,802
0.3% 11
2015
Q2
$1.97M Buy
+16,802
New +$1.84M 0.31% 12

Other funds holding GILD

Beacon Investment Advisory Services's GILD Position: Q2 2026 in Review

Beacon Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $315K and leaving 112,362 shares worth $14.2M. The position accounts for 0.53% of the portfolio, ranked #49.

Beacon Investment Advisory Services first reported a position in GILD in Q2 2015 and has held it in 45 quarters since. The position peaked at $16M in Q1 2026. 333 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Beacon Investment Advisory Services held 112,362 shares of Gilead Sciences worth $14.2M as of Q2 2026.
  • Beacon Investment Advisory Services sold 2,394 Gilead Sciences shares in Q2 2026, an estimated $315K.
  • Gilead Sciences made up 0.53% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #49 holding.
  • Beacon Investment Advisory Services first reported a position in Gilead Sciences in Q2 2015 and has held it in 45 quarters since.
  • Beacon Investment Advisory Services's Gilead Sciences position peaked at $16M in Q1 2026.
  • 333 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.